Stealth BioTherapeutics Company
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.
Investors
Headquarters:
Cayman Islands
Industry:
Oxidative Phosphorylation
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Investors Number:
8
Investor Type:
Company
Funding Status:
IPO
Number Of Exists:
Post-IPO Equity
Technology:
Geroscience
Last Funding Type:
Post-IPO Equity
Founded Date:
2007
Total Funding:
$120M